Results

Total Results: 721 records

Showing results for "drug".

281. Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KdQef_VDT2kmHDX4ddNWmR
     August 01, 2022 - Three types of IGRA are currently approved by the US Food and Drug Administration: T-SPOT.TB (Oxford … medication shown to prevent progression to active tu- berculosis; however, concerns about hepatotoxicity and drug … 1.08]); post hoc analyses showed a smaller number of cases of hepatotoxicity attributable to the study drug … increasing risk of progression to active disease (such as diabetes, lupus, cancer, alcoholism, and drug … Flu-like and other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid

282. Current Processes of the U.S. Preventive Services Task Force: Refining Evidence-Based Recommendation Development (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/currprocess.pdf
     July 01, 2007 - Food and Drug Administration, Indian Health Service, National Institutes of Health, and Veterans Administration … Food and Drug Administration), professional organiza- tions (such as the American Medical Association

283. Task Force Issues Draft Recommendation Statement on Interventions to Prevent Falls in Older Adults (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/falls-prevention-older-adults-draft-rec-bulletin.pdf
     January 08, 2024 - hazards at home or work, certain physical aspects of a person’s home or neighborhood, and alcohol or drug

284. Draft Research Plan: Breastfeeding: Primary Care Behavioral Counseling Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/breastfeeding-interventions
     March 10, 2022 - individuals or infants (e.g., persons in institutions, infants with prenatal disease, infants born to drug-using

285. Final Research Plan: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/chlamydia-and-gonorrhea-screening
     May 02, 2019 - Food and Drug Administration Outcomes KQ 1: Complications of infection (such as pelvic inflammatory

286. Final Research Plan: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cervical-cancer-screening-adults-adolescents
     March 17, 2022 - Food and Drug Administration include: the Hybrid Capture 2 High-Risk HPV DNA Test (Qiagen, Hilden, Germany

287. Archived: Final Evidence Summary: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary23/diabetes-mellitus-type-2-in-adults-screening-2008
     June 15, 2008 - older trial using a fibric acid derivative, and an older statin trial-reported that lipid-lowering drug … Pharmacoepidemiol Drug Saf 2007;16:132-43. [PMID: 17072896] Law M, Rudnicka AR. … Drug Class Review on Thiazolidinediones. … Diabetes incidence in drug trials (Text Description) Study, Year (Reference) Drug Follow-up … Lifestyle and drug interventions consistently produced a decrease in incidence of T2DM.

288. Screening for Asymptomatic Bacteriuria in Adults: Evidence for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/RoC9VuSorM_LR7sTvLeFF2
     July 01, 2008 - Screening for Asymptomatic Bacteriuria in Adults: Evidence for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement Screening for Asymptomatic Bacteriuria in Adults: Evidence for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement Kenneth Lin, MD, and Kevin Fajardo…

289. Archived: Evidence Summary: Asymptomatic Bacteriuria in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary11/asymptomatic-bacteriuria-in-adults-screening-2008
     July 15, 2008 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Asymptomatic Bacteriuria in Adults: Screening July 15, 2008 Recommendations made by the USPSTF are independent of the U.S. government. They sho…

290. Evidence Summary: Anxiety in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-anxiety-children-adolescents
     October 11, 2022 - screening; diagnostic test accuracy studies; RCTs of cognitive behavioral therapy (CBT) or US Food and Drug … Eligible pharmacotherapy interventions included agents approved by the US Food and Drug Administration … Third, the review was limited to CBT and drugs approved for pediatric use by the US Food and Drug Administration … Scale; CBT, cognitive behavioral therapy; CGAS, Children’s Global Assessment Scale; FDA, US Food and Drug

291. Screening for Syphilis: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/TzddJozNQQZYmTohr64wMz
     June 07, 2016 - services and the use of screening tests that are currently available and cleared by the US Food and Drug … 73.6%- 75.8%), patients with no risk factors for syphilis (71.5%; 95% CI, 70.4%-72.5%), or intravenous drug … 66.3%-73.3%) and slightly lower for MSM (69%; 95% CI, 66.9%- 71.0%) and MSM who were also intravenous drug … users, 69.9% MSM and intravenous drug users, 68.0% Binnicker et al,28 2012 1000 MFI followed by RPR … US Food and Drug Administration. http://www .accessdata.fda.gov/cdrh_docs/reviews/k102400 .pdf.

292. Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/uM5P-6XpsqVfEC2axGnZaD
     November 16, 2020 - US Food and Drug Administration. Products, ingredients & components. Updated May 2020. … US Food and Drug Administration. Want to quit smoking? FDA-approved products can help. … US Food and Drug Administration. Nicotrol inhaler. Updated August 2019. … US Food and Drug Administration. Highlights of prescribing information: Zyban. June 2016. … US Food and Drug Administration. Highlights of prescribing information: Chantix.

293. Recommendation: Anxiety in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-anxiety-children-adolescents
     October 11, 2022 - depression and suicide risk in children and adolescents Primary care-based interventions for illicit drug … , a serotonin–norepinephrine reuptake inhibitor, is the only medication approved by the US Food and Drug … to children and adolescents, including screening for depression, 28 suicide risk, 28 and illicit drug … Primary care-based interventions to prevent illicit drug use in children, adolescents, and young adults

294. ahrq12a_Summary_HBP.qxd (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/BXkaHRFGjwUCoyANeMSuTz
     January 01, 2010 - Adverse Effects of Treatment of Hypertension Serious or life-threatening adverse drug reactions have … Additionally, treatment of adult hypertensive patients with drug therapy and possibly nonpharmacological … Clinical effectiveness of non-drug treatment for hypertension: a meta-analysis.

295. Final Evidence Summary: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-c-screening
     March 02, 2020 - Four studies evaluated DAA regimens approved by the US Food and Drug Administration (FDA) for use in … Infect Drug Resist . 2018;11:295-298. doi:10.2147/IDR.S153060 22. … Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use ( … Int J Drug Policy . 2018;62:94-103. doi:10.1016/j.drugpo.2018.10.004 33. … baseline Most studies enrolled predominantly white participants Persons with current or recent drug

296. C97Uqjxbuhjnuondkvchzu (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/c97uqjXbUHjNuoNDkvChZu
     August 01, 2013 - The USPSTF has made recommendations on screening for illicit drug use and counseling and interventions … Monitoring the Future: National Survey Results on Drug Use, 1975–2011. … Drug Alcohol Depend. 2010;110:108-16. [PMID: 20236774] 30. Perrine MW, Peck RC, Fell JC.

297. Archived: Carotid Artery Stenosis: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening-1996
     January 01, 1996 - of atherosclerosis and reduced total cardiovascular events compared to placebo. 52A Lipid-lowering drug

298. Screening for Dementia - Recommendations and Rationale (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/T-DyWdyD67ktDMJGDp3jpm
     June 01, 2003 - There is fair to good evidence that several drug therapies have a beneficial effect on cognitive function … There is insufficient evidence to determine whether the benefits observed in drug trials are generalizable

299. Archived: Dementia in Older Adults: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/dementia-older-adults-screening-2003
     June 03, 2003 - There is fair to good evidence that several drug therapies have a beneficial effect on cognitive function … There is insufficient evidence to determine whether the benefits observed in drug trials are generalizable

300. Reports to Congress | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/reports-congress
     November 01, 2020 - These gaps include screening for prostate cancer in African American men and screening for illicit drug